| Literature DB >> 24722008 |
Sohee Park1, Yeonju Kim2, Hai-Rim Shin3, Boram Lee1, Aesun Shin1, Kyu-Won Jung1, Sun Ha Jee4, Dong Hyun Kim5, Young Ho Yun6, Sue Kyung Park7, Mathieu Boniol8, Paolo Boffetta9.
Abstract
BACKGROUND: Changes in lifestyle including obesity epidemic and reduced physical activity influenced greatly to increase the cancer burden in Korea. The purpose of the current study was to perform a systematic assessment of cancers attributable to obesity and physical inactivity in Korea. METHODOLOGY/PRINCIPALEntities:
Mesh:
Year: 2014 PMID: 24722008 PMCID: PMC3982956 DOI: 10.1371/journal.pone.0090871
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Relative risk for excess body weight and physical inactivity and related cancers in Korea (using Asian and Caucasian cut-offs for body mass index [BMI]).
| Cancer site(ICD-10 code) | Men | Women | ||
| Excess body weight (BMI | ||||
| 23≤BMI<25 | BMI≥25 | 23≤BMI<25 | BMI≥25 | |
| Colorectum (C18-C20) | 1.12 (1.06–1.19) | 1.16 (1.10–1.24) | 1.12 (1.06–1.19) | 1.16 (1.10–1.24) |
| Pancreas (C25) | 1.03 (0.92–1.15) | 1.09 (0.97–1.22) | 0.93 (0.77–1.12) | 1.15 (0.98–1.35) |
| Kidney (C64) | 1.28 (1.13–1.46) | 1.46 (1.28–1.66) | 1.53 (1.17–2.01) | 1.40 (1.07–1.83) |
| Breast (C50)c | - | - | 0.92 (0.77–1.11) | 1.26 (1.05–1.51) |
| Uterine corpus (C54) | - | - | 1.19 (0.62–2.29) | 2.65 (1.44–4.89) |
* BMI, body mass index, kg/m.
** Relative risk for colon cancer was estimated for men and women combined and also used for rectal cancer.
*** Breast cancer in postmenopausal women.
Cancer cases attributable to obesity and physical inactivity in Korea (2009).
| Obesity | ||||||
| Cancer site | Men | Women | ||||
| PAF | No. of cases | Obesity-related Cases | PAF | No. of cases | Obesity-related cases | |
| Colorectum | 6.8 | 14,949 | 1,010 | 6.6 | 9,776 | 646 |
| Pancreas | 2.9 | 2,356 | 69 | 3.9 | 1,901 | 73 |
| Kidney | 16.0 | 2,290 | 365 | 18.7 | 1,068 | 200 |
| Breast (postmenopausal) | - | - | 8.2 | 6,331 | 520 | |
| Uterine Corpus | - | - | 32.7 | 1,728 | 565 | |
| Total |
| 96,826 | 1,444 |
| 91,068 | 2,004 |
PAF, population-attributable fraction.
Prevalence of low leisure-time physical activity obtained from the 1989 Korean National Health Examination Survey (78.4% men, 87.8% women).
Prevalence (%) of excess body weight in the Republic of Korea.
| Year | Men | Women | ||||
| BMI<23 | 23≤BMI<25 | BMI≥25 | BMI<23 | 23≤BMI<25 | BMI≥25 | |
|
|
|
|
|
|
|
|
| 1998 | 50.2 | 24.4 | 25.4 | 50.5 (38.8) | 21.3 (24.0) | 28.2 (37.2) |
| 2005 | 36.2 | 27.4 | 36.4 | 46.9 (33.5) | 22.9 (26.0) | 30.2 (40.5) |
| 2007 | 38.1 | 27.1 | 34.8 | 46.8 (31.7) | 22.5 (25.8) | 30.7 (42.5) |
| 2009 | 39.2 | 25.2 | 35.6 | 48.5 (35.5) | 21.7 (26.0) | 29.8 (38.5) |
| 2015 | 32.4 | 25.6 | 42.0 | 46.1 (30.7) | 22.0 (25.9) | 32.0 (43.4) |
| 2020 | 28.5 | 25.2 | 46.3 | 45.1 (28.6) | 21.8 (26.1) | 33.1 (45.3) |
- Prevalence in postmenopausal is in parenthesis.
- BMI categories (kg/m2) for Asians: reference group, <23.0; overweight, 23.0–24.9.0; obese, ≥25.0;
- BMI categories (kg/m2) for Caucasians: reference group, <25.0; overweight, 25.0–29.0; obese, ≥30.0.
* National Health Insurance Corporation data in 1992–1995.
** Korea National Health and Nutrition Examination Survey.
*** Prevalence projected from Korean National Health and Nutrition Examination Survey data in 1992–2009.
Projected population-attributable fraction for excess body weight in Korea.
| Year of obesity prevalence | 1992 – 1995 | 1998 | 2005 | 2015 | 2020 | 2020 vs. 1992 - 1995 | ||||||
| Cancer site | No. of Cases | PAF(%) | No. of attributable cases | PAF(%) | No. of attributable cases | PAF(%) | No. of attributable cases | PAF(%) | No. of attributable cases | PAF(%) | No. of attributable cases | Difference in obesity-related cases |
|
| ||||||||||||
| Colorectum | 14,949 | 6.8 | 1,010 | 6.5 | 977 | 8.4 | 1,248 | 8.9 | 1,333 | 9.5 | 1,412 | 403 |
| Pancreas | 2,356 | 2.9 | 69 | 2.9 | 69 | 3.9 | 93 | 4.4 | 102 | 4.7 | 111 | 42 |
| Kidney | 2,290 | 16.0 | 365 | 15.6 | 358 | 19.6 | 449 | 20.9 | 480 | 22.1 | 506 | 141 |
| Total | 96,826 | 1,444 | 1,404 | 1,790 | 1,915 | 2,029 | 586 | |||||
| % of all cancers | 1.5 | 1.5 | 1.9 | 2.0 | 2.1 | |||||||
|
| ||||||||||||
| Colorectum | 9,776 | 6.6 | 645 | 6.6 | 645 | 7.1 | 689 | 7.2 | 704 | 7.3 | 717 | 71 |
| Pancreas | 1,901 | 3.9 | 73 | 4.1 | 77 | 4.3 | 82 | 4.6 | 87 | 4.7 | 90 | 17 |
| Kidney | 1,068 | 18.7 | 200 | 18.4 | 197 | 19.5 | 208 | 19.7 | 210 | 19.9 | 212 | 12 |
| Breast | 6,331 | 8.2 | 520 | 8.8 | 558 | 9.5 | 603 | 10.1 | 642 | 10.5 | 667 | 148 |
| Corpus uteri | 1,728 | 32.7 | 565 | 33.6 | 580 | 35.1 | 607 | 36.3 | 627 | 37.0 | 640 | 74 |
| Total | 91,068 | 2,004 | 2,058 | 2,190 | 2,270 | 2,326 | 322 | |||||
| % of all cancers | 2.2 | 2.3 | 2.4 | 2.5 | 2.6 | |||||||
Notes: 1) Obese and overweight prevalence data were estimated from the large-scale cohort study of National Health Insurance Corporation in1992-1995, from Korea National Health and Nutrition Survey in 1998 and 2005, and from extrapolating to 2015 and 2020; cancer incidence in 2009 was used for the calculation of projected PAF and obesity-related cases.
2) BMI categories (kg/m2): reference group, <23.0; overweight, 23.0–24.9; obese, ≥25.
* Using projected prevalence of obesity in 2015, 2020 as shown in Table 3.
Figure 1Population-attributable fractions for obesity by cancer site: (A) for Korean men and (B) for Korean women.
Figure 2Sensitivity analysis on the estimation of population-attributable fractions for obesity using the lower and upper bounds of 95% confidence intervals of relative risks.
International comparison of population-attributable fraction for excess body weight on cancer.
| Cancer site (ICD-10) | Korea | Japan | United States | United Kingdom | ||||||||||||||
| Men | Women | Men | Women | Men | Women | Men | Women | |||||||||||
| RR | PAF | RR | PAF | RR | PAF | RR | PAF | RR | PAF | RR | PAF | RR | PAF | PAF | ||||
| 23≤BMI <25 | BMI≥25 | 23≤BMI <25 | BMI≥25 | BMI≥25 | BMI≥25 | BMI≥30 | BMI≥30 | 25≤BMI <30 | BMI≥30 | |||||||||
| Colorectum (C18-20) | 1.12 | 1.16 | 6.8 | 1.12 | 1.16 | 6.6 | 1.4 | 12 | 1.1 | 3 | 1.15 | 1.32 | 13.6 | 12.2 | ||||
| Colon (C18) | 1.24 | 5.2 | 1.17 | 4.0 | ||||||||||||||
| Pancreas (C25) | 1.03 | 1.09 | 2.9 | 0.93 | 1.15 | 3.9 | 0.7 | - | 1.1 | 2.4 | 1.2 | 6 | 1.2 | 7 | 1.14 | 1.3 | 12.8 | 11.5 |
| Breast (C50) (postmenopausal; aged 50 and more) | - | - | - | 0.92 | 1.26 | 8.2 | - | - | 1.12 | 2.9 | - | - | 1.3 | 10 | 1.12 | 1.25 | - | 9.0 |
| Corpus uteri(C54) | - | - | - | 1.19 | 2.65 | 32.7 | - | - | 1.73 | 15.3 | - | - | - | - | 1.52 | 2.31 | - | 33.7 |
| Kidney (C64) | 1.28 | 1.46 | 16.0 | 1.53 | 1.40 | 18.7 | 1.66 | 13.2 | 1.55 | 12.0 | 2.0 | 25 | 2.0 | 26 | 1.31 | 1.72 | 25.0 | 22.2 |
| Esophagus (C15) (adenocarcinoma) | 3.0 | 40 | 2.6 | 36 | 1.55 | 2.4 | 26.9 | 11.2 | ||||||||||
| Gallbladder (C23) | 1.4 | 12 | 2.0 | 26 | 1.23 | 1.51 | 19.7 | 17.8 | ||||||||||
| Prevalence (%) | ||||||||||||||||||
| Overweight | 26.1 (28.5) | 27.5 (23.2) | 23.0 | 24.7 | - | - | 25∼52 | 25∼41 | ||||||||||
| Obesity | 1.4 (23.9) | 3.2 (26.8) | 33.3 | 35.3 | 17∼32 | 14∼30 | ||||||||||||
| % of all cancers | 1.5 | 2.2 | 0.8 | 1.6 | 4.4 | 7.5 | 4.1 | 6.9 | ||||||||||
* Prevalence categorized for 25≤BMI<30, BMI≥30 from the 1996–1997 records of the National Health Insurance Cooperation; parenthesis represent each of 23≤BMI<25, BMI≥25 from 1992–1995 records of the National Health Insurance Cooperation, which were used for PAF calculation.
** Prevalence data for 1990 from pooled analysis of 6 prospective cohort studies, categorized BMI≥25 for overweight and obesity.
Range of prevalence by age groups in 2000–2001, data from the Nation Diet and Nutrition Survey (ages 19–64)/Health Survey for England (ages >65) [27].
PAF also includes contribution from cancers of endometrium, gastric cardia, liver, thyroid, and leukemia, myeloma, and non-Hodgkin's lymphoma.